Patent · US Active

N,N-bis-2-mercaptoethyl isophthalamide for the treatment of neurodegenerative diseases

US11628151B2 · kind B2 · utility

0Cited by

1References

10Claims

0Family size

Assignee

EMERAMED LIMITED · IE

Inventors

Boyd E. Haley · Nicholasville, US
Ragnar Axel Theodor KLINGBERG · Stockholm, SE

Key dates

Filing date	Sep 27, 2022
Grant date	Apr 18, 2023
Priority date	—
Expiry date	Sep 27, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

According to the invention there is provided N,N-bis-2-mercaptoethyl isophthalamide, or a pharmaceutically acceptable salt or derivative thereof, for use in the therapeutic treatment of a neurodegenerative disorder, such as Alzheimer's disease, Parkinson's disease, Huntington's disease and/or amyotrophic lateral sclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.